[Carbon monoxide poisoning in active or passive shisha smokers].

Intoxication au monoxyde de carbone chez les fumeurs actifs ou passifs de chicha.

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
May 2020
Historique:
received: 22 08 2019
accepted: 09 10 2019
pubmed: 27 4 2020
medline: 31 10 2020
entrez: 27 4 2020
Statut: ppublish

Résumé

In France, shisha (narghile) smoking is increasingly popular among adolescents and young adults and is generally thought to be less harmful and addictive than cigarettes. This systematic review of data on carbon monoxide (CO) poisoning in active or passive shisha tobacco smokers selected 17 studies. Sixteen case reports, including 39 patients (mean age: 22.3 years; males: 51.3%), described acute carbon monoxide poisoning in active shisha smokers. The most common symptoms were dizziness, headache, and nausea. Loss of consciousness occurred in 43.6% of patients. Two patients had an epileptic seizure. The mean carboxy-haemoglobin (HbCO) blood level was 17.3%. Electrocardiographic changes were present in five patients. Most patients were treated with normobaric oxygen therapy while only four received hyperbaric oxygen therapy; two of whom were non tobacco smokers exposed to shisha smoke during their work. The outcome was favourable in all patients. Shisha use must be suspected in cases of CO poisoning, especially in adolescents and young adults. Practitioners must help shisha users to stop their consumption.

Identifiants

pubmed: 32334968
pii: S0761-8425(20)30105-4
doi: 10.1016/j.rmr.2019.10.013
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Systematic Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

376-388

Informations de copyright

Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M Underner (M)

Unité de recherche clinique, centre hospitalier Henri-Laborit, université de Poitiers, 370, avenue Jacques-Cœur, CS 10587, 86021 Poitiers, France. Electronic address: mike.underner@orange.fr.

J Perriot (J)

Dispensaire Emile-Roux, CLAT 63, centre de Tabacologie, 63100 Clermont-Ferrand, France.

G Peiffer (G)

Service de pneumologie, CHR de Metz-Thionville, 57038 Metz, France.

J D Dewitte (JD)

Laboratoire d'étude et de recherche en sociologie (EA 3149), Université de Brest, Bretagne-Occidentale, 29200 Brest, France; Service de Santé au travail et des maladies liées à l'environnement, CHRU de Morvan, 29609 Brest, France.

N Jaafari (N)

Unité de recherche clinique, centre hospitalier Henri-Laborit, université de Poitiers, 370, avenue Jacques-Cœur, CS 10587, 86021 Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH